Showing results (61-70 of 196) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|June 6, 2017
Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort studyPaolo Strati, Sameer A Parikh, Kari G Chaffee, et al.
Leukemia & Lymphoma|August 3, 2012
Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximabClive S Zent, Wenting Wu, Deborah A Bowen, et al.
Leukemia & Lymphoma|May 26, 2010
Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemiaTait D Shanafelt, Kari G Rabe, Neil E Kay, et al.
Mayo Clinic Proceedings|April 10, 2007
Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic testGrzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, et al.
Leukemia Research|July 1, 2008
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximabClive S Zent, Charla R Secreto, Betsy R LaPlant, et al.
Leukemia & Lymphoma|November 30, 2013
Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphomaMichael J Conte, Deborah A Bowen, Gregory A Wiseman, et al.
Leukemia Research|July 29, 2008
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemiaTait D Shanafelt, Deborah A Bowen, Chaya Venkat, et al.
Cancer|December 18, 2008
Validation of a new prognostic index for patients with chronic lymphocytic leukemiaTait D Shanafelt, Greg Jenkins, Timothy G Call, et al.
Leukemia & Lymphoma|March 23, 2010
Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisoneDeborah A Bowen, Timothy G Call, Tait D Shanafelt, et al.
Leukemia & Lymphoma|December 11, 2007
Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic featuresDeborah A Bowen, Timothy G Call, Greg D Jenkins, et al.
Pageof 20